Home Start
Lecture
Presentation
Download
Podcast
Enter
Learning Assessment
& Evaluation
Download
Activity
Workbook

OVERVIEW
This free CE activity consists of a presentation, a learning assessment, and an evaluation. This virtual lecture is derived from a satellite symposium presented on April 27, 2013, in conjunction with the Oncology Nursing Society 38th Annual Congress in Washington, DC.

MEDIUM: Virtual Lecture
INTERNET RELEASE DATE: July 15, 2013
CE AVAILABLE UNTIL: January 15, 2015

Estimated time to complete this activity: 1.5 hours


TARGET AUDIENCE
This activity has been designed to meet the education needs of nurses, social workers and other healthcare professionals involved in the care of patients living with hematologic cancers.


PROGRAM GOAL
Oncology nursing management includes thorough knowledge of drug administration and awareness of adverse effects, including those that may cause serious and life-threatening issues. Nurses must be not only knowledgeable about administering medicines and managing possible reactions, it is also important for nurses to initiate and foster ongoing communication about side effects management and treatment adherence with both other treatment team members and with patients.

With a number of new hematologic cancer drug approvals, as well as new indications, or newly approved methods of administration for approved drugs, continuing nursing education is essential.

Through discussion of case studies, this symposium will provide the opportunity for nurses to build their knowledge about administering some of the current therapies used to treat hematologic malignancies. Monitoring and managing possible serious reactions, including infection, and communications among nurses, other treatment team members, and patients will be discussed.


EDUCATION OBJECTIVES
After completing this activity, the participant should be better able to:

  • List three new drugs/new applications of drugs to treat patients with blood cancer
  • Explain methods of administration for two new drugs to treat patients with blood cancer
  • Describe the importance of monitoring side effects and treatment adherence
  • Identify management of two potential treatment side effects
  • Identify two communication touchpoints on side effects management and treatment adherence for nurses and patients

METHOD OF PARTICIPATION
To complete this activity and receive a statement of credit, participants must:

  1. Review all contents of this activity
  2. Complete and submit the learning assessment and evaluation form
  3. Score at least 70% on the learning assessment

CONTINUING EDUCATION INFORMATION FOR NURSES AND SOCIAL WORKERS
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under provider number CEP 5832 to award 1.5 continuing education contact hours through the California Board of Registered Nursing.

The Leukemia & Lymphoma Society (LLS), provider number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org Approved Continuing Education Program (ACE). Approval Period: December 2011 - December 2014. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 1.5 CE clinical clock hours.

Upon successful completion of the entire program, learning assessment (grade of 70% or higher) and submission of the activity evaluation, a certificate of completion will be issued to you within 30 days, via email or US mail based on your designation on the evaluation.


SUPPORT STATEMENT
This program is supported by grants from Millennium: The Takeda Oncology Company and Spectrum Pharmaceuticals.


FACULTY
Kevin Brigle, PhD, ANP
Oncology Nurse Practitioner
Massey Cancer Center
Virginia Commonwealth University Health System
Richmond, VA

Amy Goodrich, ACNP-BC
Nurse Practitioner
Johns Hopkins Kimmel Cancer Center
Baltimore, MD

Sylvia K. Wood, DNP, ANP-BC
Adult Nurse Practitioner
Associate Director, BMT Clinical Research Program
Hematologic Malignancy Stem Cell Transplant Program
Stony Brook University Medical Center
Stony Brook, NY


FEE INFORMATION
There is no fee for this educational activity.


QUESTIONS AND TECHNICAL ASSISTANCE
For questions regarding the content of this activity, please contact an LLS Information Specialist at
800-955-4572, or infocenter@lls.org. For technical assistance, contact jungsen@rmcom.net.


SYSTEM REQUIREMENTS
Hardware/Software requirements include:
• Windows 95, 98se, ME, XP, NT 4.0, 2000   
  - Internet Explorer 4.0+
  - Netscape Navigator 6.2+
  - Mozilla Firefox 1.0+

• Macintosh 9.2, OS X 10.1+
  - Safari 1.1+
  - Netscape Navigator 6.2+
  - Internet Explorer 5.2+
  - Mozilla Firefox 1.0+

• Additional Requirements
  - Adobe Flash Player 7.0+
  - Adobe Reader 7.0+
  - Internal/external speakers
  - Broadband connection (DSL/cable) recommended

 

 

RMEI Privacy Statement

For questions, grievances, assistance for people with disabilities or more information on LLS programs, please contact an LLS Information Specialist at (800) 955-4572.